查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132497

開放性青光眼市場規模、佔有率和趨勢分析報告：按手術方式、類型、最終用途、地區和細分市場分類（2026-2033 年）

Open Angle Glaucoma Market Size, Share & Trends Analysis Report By Procedure (Bleb-based Procedure, Non-bleb-based Procedure), By Type (Combined, Standalone), By End Use (Inpatient, Outpatient), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

開放性青光眼市場概述

全球開放性青光眼市場預計到 2025 年將達到 10 億美元，到 2026 年將成長到 11 億美元，到 2033 年將達到 21 億美元，2026 年至 2033 年的複合年成長率為 9.6%。

預計到2025年，北美市場將成為市場成長的主要驅動力，佔全球銷售額的41.4%。開放性青光眼（OAG）是全球不可逆性視力喪失的主要原因之一，其疾病負擔受到人口老化、預期壽命延長和近視盛行率上升的影響。由於人口結構、遺傳易感性、醫療保健服務可近性和疾病檢出率的差異，該疾病的負擔在不同地區有所不同。預計這些流行病學趨勢將增加對青光眼篩檢、診斷、後續觀察和治療的需求，從而持續支撐全球開放性青光眼（OAG）相關內科和外科治療的需求。

開放性青光眼市場的發展主要得益於診斷、監測和治療技術的進步，包括光學同調斷層掃描（OCT）、人工智慧輔助的青光眼篩檢、先進的視野檢查、微創青光眼手術（MIGS）以及緩釋藥物傳輸解決方案。這些技術的日益普及使得疾病進展的早期檢測和個人化治療方案的發展成為可能，同時減少了對傳統療法的依賴。此外，全球青光眼負擔的加重、人口老化以及對早期診斷和長期疾病管理的日益重視（旨在預防不可逆轉的視力喪失）也進一步推動了這一趨勢。

整體而言，開放性青光眼市場的發展得益於多種因素的共同推動，包括疾病負擔日益加重、人口老化、人們對定期眼科檢查重要性的認知不斷提高，以及診斷和治療領域技術的持續進步。這種向更積極主動、技術主導的疾病管理模式轉變，預計將在未來幾年繼續成為影響市場發展的關鍵因素。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：開放性青光眼市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 開放性青光眼市場分析工具

第4章：開放性青光眼市場：依手術類型分類的估算與趨勢分析

  • 開放性青光眼市場：依手術方式分類的趨勢分析。
  • 開放性青光眼市場：依手術方式分類的展望。
  • 市場規模、預測與趨勢分析，2021-2033年
  • 基於水皰的治療
    • 穿孔（瘻管形成）型濾過泡手術
    • 非穿孔性濾過泡法（NPDS）
  • 無泡法

第5章：開放性青光眼市場：按類型分類的估算與趨勢分析

  • 開放性青光眼市場：按類型分類的趨勢分析
  • 開放性青光眼市場：按類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 獨立版
  • 一體化

第6章：開放性青光眼市場：依最終用途分類的估算與趨勢分析

  • 開放性青光眼市場：依最終用途分類的趨勢分析。
  • 開放性青光眼市場：依最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 住院治療
  • 門診

第7章：開放性青光眼市場：區域估算與趨勢分析

  • 區域儀錶板
  • 開放性青光眼市場波動區域分析
  • 開放性青光眼市場：區域估算與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • Glaukos Corporation
    • Alcon Inc.
    • Sight Sciences, Inc.
    • Johnson & Johnson Vision Care, Inc.
    • New World Medical, Inc.
    • IRIDEX Corporation
    • Santen Pharmaceutical Co., Ltd.
    • Nova Eye Medical Limited
    • iSTAR Medical SA
    • Carl Zeiss Meditec AG
    • Lumenis Ltd.
    • ViaLase, Inc.
    • Lumibird SA
    • Oertli Instrumente AG
Product Code: GVR-4-68041-009-8

Open Angle Glaucoma Market Summary

The global open angle glaucoma market size was valued at USD 1.0 billion in 2025 and is projected to grow from USD 1.1 billion in 2026 to USD 2.1 billion by 2033, at a CAGR of 9.6% from 2026 to 2033. The market in North America dominated with a revenue share of 41.4% in 2025. Open-angle glaucoma (OAG) is a major cause of irreversible vision loss worldwide, with its burden influenced by population aging, increasing life expectancy, and rising prevalence of myopia. The disease burden varies across regions due to differences in demographics, genetic predisposition, healthcare access, and disease detection rates. These epidemiological trends are expected to increase the need for glaucoma screening, diagnosis, monitoring, and treatment, thereby supporting sustained global demand for OAG-related medical and surgical interventions.

The open-angle glaucoma market is being supported by advances in diagnostic, monitoring, and therapeutic technologies, including optical coherence tomography (OCT), AI-enabled glaucoma screening, advanced visual field testing, minimally invasive glaucoma surgery (MIGS), and sustained drug-delivery solutions. Increasing adoption of these technologies enables earlier disease progression and personalized treatment planning while reducing dependence on conventional approaches. This trend is further supported by the growing global burden of glaucoma, population aging, and increasing emphasis on early diagnosis and long-term disease management to prevent irreversible vision loss.

Overall, the open-angle glaucoma market is supported by a combination of rising disease burden, aging populations, greater awareness of regular eye examinations, and continued technological advancements across diagnosis and treatment. This shift toward more proactive and technology-driven disease management is expected to remain an important factor shaping the market over the coming years.

Global Open Angle Glaucoma Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the open angle glaucoma market report on the basis of procedure, type, end use, and region:

  • Procedure Outlook (Revenue, USD billion, 2021 - 2033)
  • Bleb-based Procedures
    • Perforating (Fistulizing) Bleb-based Procedures
    • Non-Perforating Bleb-Based Procedures (NPDS)
  • Non-Bleb-Based Procedures
  • Type Outlook (Revenue, USD billion, 2021 - 2033)
  • Standalone
  • Combined
  • End Use Outlook (Revenue, USD billion, 2021 - 2033)
  • Inpatient
  • Outpatient
  • Regional Outlook (Revenue, USD billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure outlook
    • 2.2.2. Type outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Open Angle Glaucoma Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Open Angle Glaucoma Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Open Angle Glaucoma Market: Procedure Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Open Angle Glaucoma Market: Procedure Movement Analysis
  • 4.3. Open Angle Glaucoma Market by Procedure Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Bleb-based Procedures
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Perforating (Fistulizing) Bleb-based Procedures
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Non-Perforating Bleb-Based Procedures (NPDS)
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Non-Bleb-Based Procedures
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Open Angle Glaucoma Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Open Angle Glaucoma Market: Type Movement Analysis
  • 5.3. Open Angle Glaucoma Market by Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Standalone
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Combined
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Open Angle Glaucoma Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Open Angle Glaucoma Market: End Use Movement Analysis
  • 6.3. Open Angle Glaucoma Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Inpatient
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Outpatient
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Open Angle Glaucoma Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Open Angle Glaucoma Market Movement Analysis
  • 7.3. Open Angle Glaucoma Market: Regional Estimates & Trend Analysis by Procedure
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Open Angle Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Glaukos Corporation
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Procedure benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Alcon Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Procedure benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Sight Sciences, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Procedure benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Johnson & Johnson Vision Care, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Procedure benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. New World Medical, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Procedure benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. IRIDEX Corporation
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Procedure benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Santen Pharmaceutical Co., Ltd.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Procedure benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Nova Eye Medical Limited
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Procedure benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. iSTAR Medical SA
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Procedure benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Carl Zeiss Meditec AG
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Procedure benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Lumenis Ltd.
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Procedure benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. ViaLase, Inc.
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Procedure benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. Lumibird SA
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Procedure benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. Oertli Instrumente AG
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Procedure benchmarking
      • 8.2.14.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 4. Global Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 5. Global Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6. North America Open Angle Glaucoma Market, by Country, 2021 - 2033 (USD Million)
  • Table 7. North America Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 8. North America Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 9. North America Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 10. U.S. Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 11. U.S. Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 12. U.S. Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13. Canada Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 14. Canada Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 15. Canada Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16. Mexico Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 17. Mexico Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 18. Mexico Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 19. Europe Open Angle Glaucoma Market, by Country, 2021 - 2033 (USD Million)
  • Table 20. Europe Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 21. Europe Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 22. Europe Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 23. UK Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 24. UK Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 25. UK Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 26. Germany Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 27. Germany Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 28. Germany Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29. France Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 30. France Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 31. France Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 32. Italy Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 33. Italy Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 34. Italy Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 35. Spain Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 36. Spain Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 37. Spain Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38. Denmark Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 39. Denmark Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 40. Denmark Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41. Sweden Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 42. Sweden Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 43. Sweden Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 44. Norway Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 45. Norway Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 46. Norway Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Open Angle Glaucoma Market, by Country, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 51. China Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 52. China Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 53. China Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54. Japan Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 55. Japan Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 56. Japan Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57. South Korea Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 58. South Korea Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 59. South Korea Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 60. Thailand Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 61. Thailand Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 62. Thailand Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 63. Australia Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 64. Australia Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 65. Australia Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66. India Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 67. India Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 68. India Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 69. Latin America Open Angle Glaucoma Market, by Country, 2021 - 2033 (USD Million)
  • Table 70. Latin America Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 71. Latin America Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 72. Latin America Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 73. Brazil Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 74. Brazil Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 75. Brazil Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 76. Argentina Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 77. Argentina Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 78. Argentina Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa Open Angle Glaucoma Market, by Country, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83. South Africa Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 84. South Africa Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 85. South Africa Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 89. UAE Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 90. UAE Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 91. UAE Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)
  • Table 92. Kuwait Open Angle Glaucoma Market, by Procedure, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Open Angle Glaucoma Market, by Type, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Open Angle Glaucoma Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig 1. Information Procurement
  • Fig 2. Primary Research Pattern
  • Fig 3. Market Research Approaches
  • Fig 4. Value Chain-Based Sizing & Forecasting
  • Fig 5. Market Formulation & Validation
  • Fig 6. Open angle glaucoma market segmentation
  • Fig 7. Market driver analysis (Current & future impact)
  • Fig 8. Market restraint analysis (Current & future impact)
  • Fig 9. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig 10. Porter's Five Forces Analysis
  • Fig 11. Open angle glaucoma market, procedure outlook key takeaways (USD Million)
  • Fig 12. Open angle glaucoma market procedure movement analysis (USD Million), 2025 & 2033
  • Fig 13. Bleb-based procedures market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 14. Perforating (fistulizing) bleb-based procedures market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 15. Non-perforating bleb-based procedures (NPDS) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 16. Non-bleb-based procedures market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 17. Open angle glaucoma market, type outlook key takeaways (USD Million)
  • Fig 18. Open angle glaucoma market type movement analysis (USD Million), 2025 & 2033
  • Fig 19. Standalone market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 20. Combined market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 21. Open angle glaucoma market, end use outlook key takeaways (USD Million)
  • Fig 22. Open angle glaucoma market end use movement analysis (USD Million), 2025 & 2033
  • Fig 23. Inpatient market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 24. Outpatient market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 25. Open angle glaucoma market: Regional key takeaways (USD Million)
  • Fig 26. Open angle glaucoma market regional outlook, 2025 & 2033, USD Million
  • Fig 27. North America open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 28. U.S. open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 29. Canada open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 30. Mexico open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 31. Europe open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 32. UK open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 33. Germany open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 34. France open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 35. Spain open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 36. Italy open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 37. Sweden open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 38. Norway open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 39. Denmark open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 40. Asia Pacific open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 41. China open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 42. Japan open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 43. India open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 44. South Korea open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 45. Australia open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 46. Thailand open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 47. Latin America open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 48. Brazil open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 49. Argentina open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 50. Middle East and Africa open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 51. South Africa open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 52. Saudi Arabia open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 53. UAE open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 54. Kuwait open angle glaucoma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 55. List of key emerging company's/indication disruptors/innovators